Clinical value of nodal micrometastases in patients with non-small cell lung cancer: time for reconsideration?

Affiliations

Comment

Angelo Carretta. J Thorac Dis. 2016 Dec.

. 2016 Dec;8(12):E1755-E1758.

doi: 10.21037/jtd.2016.12.83.

¹ Department of Thoracic Surgery, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.

No abstract available

Conflict of interest statement

The author has no conflicts of interest to declare.

Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer.
Garelli E, Renaud S, Falcoz PE, Weingertner N, Olland A, Santelmo N, Massard G. Garelli E, et al. Eur J Cardiothorac Surg. 2016 Aug;50(2):322-8. doi: 10.1093/ejcts/ezw036. Epub 2016 Feb 25. Eur J Cardiothorac Surg. 2016. PMID: 26920941

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30. 10.3322/caac.21332 - DOI - PubMed
1. Union for International Cancer Control. International Union Against Cancer. TNM Classification of Malignant Tumors. 7th Ed. New York: Wiley-Blackwell, 2009.
1. Nosotti M, Falleni M, Palleschi A, et al. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker. Chest 2005;128:1539-44. 10.1378/chest.128.3.1539 - DOI - PubMed
1. Rusch VW, Hawes D, Decker PA, et al. Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol 2011;29:4313-9. 10.1200/JCO.2011.35.2500 - DOI - PMC - PubMed
1. Marchevsky AM, Gupta R, Kusuanco D, et al. The presence of isolated tumor cells and micrometastases in the intrathoracic lymph nodes of patients with lung cancer is not associated with decreased survival. Hum Pathol 2010;41:1536-43. 10.1016/j.humpath.2010.04.006 - DOI - PubMed